Catalym
Vanja Radulovic is a Clinical Trial Manager at CatalYm GmbH since January 2025, with extensive experience in managing international clinical trials across various companies. Prior roles include Clinical Project Manager at EirGenix, Inc. and Clinical Trial Manager at 4SC AG, where responsibilities encompassed regulatory submissions, document quality control, and project-specific reporting. Previous experience as Clinical Research Project Coordinator II at Medpace involved project timelines and status report management. Earlier positions include trainee roles focusing on Life Science product development and a Ph.D. program at the Technical University of Munich, where research centered on the detection of miRNAs in cancer contexts. Educational credentials also include a Master's degree in Soil Microbiology from the University of Belgrade.
This person is not in any teams
Catalym
Catalym develops antibodies against a placental factor which is overexpressed by various tumour types.